Common Contracts

EX-2.1 2 d656574dex21.htm EX-2.1

Asset Purchase Agreement • May 5th, 2020 • New York

• Contract Type
  Asset Purchase Agreement
• Filed
  May 5th, 2020
• Jurisdiction
  New York

[*] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.

ASSET PURCHASE AGREEMENT by and among JAZZ PHARMACEUTICALS INTERNATIONAL III LIMITED, AERIAL BIOPHARMA, LLC and JAZZ PHARMACEUTICALS PLC Dated January 13, 2014

Asset Purchase Agreement • January 13th, 2014 • Jazz Pharmaceuticals PLC • Pharmaceutical preparations • New York

• Contract Type
  Asset Purchase Agreement
• Filed
  January 13th, 2014
• Company
  Jazz Pharmaceuticals PLC
• Industry
  Pharmaceutical preparations
• Jurisdiction
  New York

This Asset Purchase Agreement (this “Agreement”) is entered into on January 13, 2014, by and among Jazz Pharmaceuticals International III Limited, a Bermuda company limited by shares (“Buyer”), Aerial BioPharma, LLC, a North Carolina limited liability company (the “Company”) and, solely for purposes of Section 5.9, Jazz Pharmaceuticals Public Limited Company, a public limited company formed under the laws of Ireland (“Parent”).